Gemcitabine and epirubicin in patients with malignant pleural mesothelioma (MPM): A North Central Cancer Treatment Group phase II study
| Autor: | James A. Mailliard, Robert Delaune, Nathan R. Foster, Brian M. Bot, Marie Christine Aubry, Jeff A. Sloan, James R. Jett, Scott H. Okuno, Daniel A. Nikcevich, Kendrith M. Rowland |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Chemotherapy North central business.industry medicine.medical_treatment Phases of clinical research medicine.disease Gemcitabine Cancer treatment Internal medicine polycyclic compounds medicine In patient skin and connective tissue diseases business Progressive disease Epirubicin medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 23:7264-7264 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2005.23.16_suppl.7264 |
| Popis: | 7264 Background: MPM is a relentlessly progressive disease. Optimal chemotherapy for MPM is unknown, but there is preclinical evidence of cytotoxic synergy between gemcitabine (G) and epirubicin (E... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|